Doxycycline inhibits breast cancer EMT and metastasis through PAR-1/NF-κB/miR-17/E-cadherin pathway.
Zhong W, Chen S, Qin Y, Zhang H, Wang H, Meng J, Huai L, Zhang Q, Yin T, Lei Y, Han J, He L, Sun B, Liu H, Liu Y, Zhou H, Sun T, Yang C.
Zhong W, et al. Among authors: zhang q, zhang h.
Oncotarget. 2017 Aug 24;8(62):104855-104866. doi: 10.18632/oncotarget.20418. eCollection 2017 Dec 1.
Oncotarget. 2017.
PMID: 29285218
Free PMC article.